TTrialPathMatch Me to Trials
← Back to trials
RecruitingObesity and Overweight

Total-body Glucose Utilization in Obesity

Eligible age

20–60 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

There are three goals for this study. One is to investigate how different emotions and exposure to cold affect blood flow in the body. The second aim is to study how insulin affects blood flow and tissue glucose uptake, and to study whether this effect is altered in obesity. Last, the study focuses on establishing the lowest dose of a PET radiotracer, oxygen-15 labelled water, that can be used in clinical studies with a new whole-body PET scanner.

Sponsor: Turku University Hospital

You may qualify if…

  • ✓ 1. Age 20-60 years
  • ✓ 2. BMI either 18.5-25 kg/m2 or above 30 kg/m2
  • ✓ 3. Use of hormonal contraception for women in child bearing age

You may not qualify if…

  • ✕ 1. In the lean group history of obesity or type 2 diabetes
  • ✕ 2. In the group with obesity: current or previous use of GLP-1-agonists or insulin
  • ✕ 3. History of eating disorders
  • ✕ 4. Smoking, use of narcotics, excessive use of alcohol
  • ✕ 5. Previous participation in PET studies
  • ✕ 6. Previous significant exposure to radiation
  • ✕ 7. Claustrophobia
  • ✕ 8. Active plans for concieving (both sexes)

Source: ClinicalTrials.gov · NCT06739473 · last updated 2024-12-18